-
Sanofi's BTK inhibitor is declared for market in China
New Beijing News (Reporter Zhang Zhaohui) On December 30th, the official website of the Drug Evaluation Center of the National Medical Products Administration announced that the application for the l ... -
Apple is rumored to have preliminary discussions with Tencent and ByteDance to consider embedding their AI models into iPhones sold in China
Xinhua Finance, Shanghai, December 19 According to several insiders, Apple is negotiating with Tencent and ByteDance to integrate their AI models into iPhones sold in China. On December 12th, OpenAI ... -
Nvidia expands in China against the trend, attracting talent and adding hundreds of R&D personnel in one year
Recently, it was exclusively learned by industry insiders that Nvidia has been recruiting research and development talents in China over the past year. On November 25th, Nvidia opened its new office ... -
The CEO of the world's fourth largest car company, Stellantis, has resigned and adjusted the person in charge of related business in China
[align center] (Stellantis Group recently released the interim executive committee structure. Interviewee/image) After the sudden resignation of CEO Carlos Tavares, Stellantis Group continued to cor ... -
The CEO of the world's fourth largest car company, Stellantis, has resigned and adjusted the person in charge of related business in China
[align center] (Stellantis Group recently released the interim executive committee structure. Interviewee/image) After the sudden resignation of CEO Carlos Tavares, Stellantis Group continued to cor ... -
Merck PD-1 inhibitor pembrolizumab's fourth lung cancer indication approved in China
On December 3rd, Merck announced that its PD-1 inhibitor pembrolizumab (trade name: CRDA®) We have obtained approval from the National Medical Products Administration (NMPA) of China to combine p ... -
Honda accelerates its electrification layout in China, with joint ventures intensively deploying electric vehicles
To be honest, our current situation in China is indeed very difficult. The market competition is very fierce now. Guangzhou Honda used to focus more on the field of fuel vehicles. Now, 50% of China's ... -
A sharp drop of 87%! Maserati will only sell over 30 units in China in September! Has the 'Sports Car Queen' fallen from grace?
The intense competition in the car market has made even ultra luxury car brands unable to withstand it. Recently, the National Passenger Car Market Information Joint Conference released statistical d ... -
AbbVie Dual Anti Cancer New Drug Declares for Market in China
On November 6th, the latest announcement on the official website of the Center for Drug Evaluation (CDE) of the National Medical Products Administration stated that AbbVie's application for the launc ... -
Pfizer's innovative targeted therapy drug Taizena has been approved in China
The reporter learned that Pfizer's innovative drug for treating prostate cancer, Terzena& reg; （TALZENNA®， The generic name: Terazopanib Tosylate Capsules was approved by the National Medical P ... -
This US funded enterprise has clarified its confidence and direction for development in China through the CIIE
Shanghai, November 3 (Xinhua) - Boston Scientific, a US funded medical device company, recently announced two news in Shanghai. Firstly, its first production and manufacturing base in China has been ... -
Dialogue with Meng Pu, Chairman of Qualcomm China: Qualcomm has long-term accumulation in China and will adhere to the path of self-developed chips
At last week's Snapdragon Summit, Qualcomm released the new generation Snapdragon 8 Elite mobile platform and two brand new in car platforms. After the annual event, Meng Pu, Chairman of Qualcomm Chi ... -
When will Apple AI be launched in China? Cook responds!
According to Interface News, on October 23rd, Tim Cook, CEO of Apple Inc. (AAPL, stock price $235.86, market value $3.6 trillion), responded to a reporter's question during a visit to Weibo about whe ... -
The Boston Science Harbor Base has been completed and opened, achieving "independent production" in China
On October 15th, the first production and manufacturing base of Boston Scientific China, the Boston Scientific Port Base, was completed and opened, focusing on the production of medical consumables a ... -
Hyatt Hotels and China Resources Land establish a joint venture for light asset expansion, continuing to expand into the Chinese market
Reporter Shu Dongni On October 15th, Hyatt Hotels, an international hotel group, announced the establishment of a joint venture company, Runkai Holdings Limited, with China Resources Land, and signed ... -
Has the 'fixed price' policy been effective? General Motors' sales in China increased by 14.3% month on month in the third quarter, and SAIC GM's orders for certain models were overstocked
Recently, General Motors disclosed that in the third quarter of this year, the sales of cars by General Motors and its joint ventures in China exceeded 426000 units, a year-on-year decrease of 21%, b ... -
General Motors Q3 sold over 420000 vehicles in China, surpassing gasoline powered vehicles for the first time in new energy vehicles
China Economic Net, October 10th (Reporter Jiang Zhiwen) General Motors released data today showing that in the third quarter of this year, its retail sales in the Chinese market exceeded 420000 vehi ... -
Sanofi: Targeted therapy drug for chronic obstructive pulmonary disease (COPD), Dabitou, approved in China
On September 27th, Sanofi announced that Dapitumab Injection has been approved by the China National Medical Products Administration for use in adult patients with chronic obstructive pulmonary disea ... -
The targeted therapy drug for chronic obstructive pulmonary disease, Dabitou, has been approved in China
Southern Finance and Economics, September 27th - Sanofi announced that Dabitou& reg; Dupilumab injection has been approved by the National Medical Products Administration (NMPA) of China for use in a ... -
Sanofi's targeted therapy drug for chronic obstructive pulmonary disease, Dabitou, has been approved in China
On September 27th, Sanofi announced that Dapitumab Injection has been approved by the China National Medical Products Administration for use in adult patients with chronic obstructive pulmonary disea ...